The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations
- 5 March 2013
- journal article
- clinical trial
- Published by BMJ in Journal of Clinical Pathology
- Vol. 66 (5), 441-445
- https://doi.org/10.1136/jclinpath-2012-201345
Abstract
BRAF V600R-M-D are uncommon mutations, not included in the experimental protocols of BRAF selective inhibitors. We report the evaluation of correlations among different types of BRAF somatic mutations in melanoma and their management with BRAF inhibitors. 21 patients with BRAF mutated metastatic melanoma were enrolled in the protocol with BRAF inhibitors for compassionate use at the University of Modena. Hot spot V600E mutations were found in 19 patients. V600R mutation and double (V600E -V600M) mutation were identified in two melanomas. In one case, V600K mutation was found. Two screening failures were noted. Mean progression free survival at follow-up of to 8 weeks, was 7.6 months. Five patients had a very short follow-up and the experimental protocol is still ongoing, so we cannot provide complete follow-up data. However, all of them are still under treatment and disease progression free. An objective response with few side effects was observed in all patients. in vitro studies with the aim of testing drug sensitivity.Keywords
This publication has 17 references indexed in Scilit:
- Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanomaJournal of Hematology & Oncology, 2012
- High-Resolution Melting Analysis as a Sensitive Prescreening Diagnostic Tool to Detect KRAS, BRAF, PIK3CA, and AKT1 Mutations in Formalin-Fixed, Paraffin-Embedded TissuesArchives Of Pathology & Laboratory Medicine, 2012
- The role of BRAF V600 mutation in melanomaJournal of Translational Medicine, 2012
- PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA MutationsJournal of Clinical Oncology, 2012
- Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art TechniquesCase Reports in Oncology, 2012
- BRAF Mutations in Advanced Cancers: Clinical Characteristics and OutcomesPLOS ONE, 2011
- Combinatorial Treatments That Overcome PDGFRβ-Driven Resistance of Melanoma Cells to V600EB-RAF InhibitionCancer Research, 2011
- Targeting BRAF in Advanced Melanoma: A First Step toward Manageable DiseaseClinical Cancer Research, 2011
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- Detection of BRAF V600E Mutation in Colorectal Cancer: Comparison of Automatic Sequencing and Real-Time Chemistry MethodologyThe Journal of Molecular Diagnostics, 2006